313 related articles for article (PubMed ID: 17038001)
21. [Bone marrow transplantation for severe aplastic anemia].
Bullorsky EO; Bonduel M; Shanley C; Figueroa C; Stemmelin G; Del Pozo A; Ceresetto J; Delfino S; Puppo M; Muriel FS
Medicina (B Aires); 1998; 58(2):130-4. PubMed ID: 9706244
[TBL] [Abstract][Full Text] [Related]
22. Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA.
Lawler M; McCann SR; Marsh JC; Ljungman P; Hows J; Vandenberghe E; O'Riordan J; Locasciulli A; Socié G; Kelly A; Schrezenmeier H; Marin P; Tichelli A; Passweg JR; Dickenson A; Ryan J; Bacigalupo A;
Br J Haematol; 2009 Mar; 144(6):933-45. PubMed ID: 19183198
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients].
Arranz R; Steegmann JL; Fernández-Garesse D; Figuera A; Vázquez L; Fernández-Rañada JM
Rev Clin Esp; 1989 Feb; 184(3):121-4. PubMed ID: 2655043
[TBL] [Abstract][Full Text] [Related]
24. The influence of cyclosporin alone, or cyclosporin and methotrexate, on the incidence of mixed haematopoietic chimaerism following allogeneic sibling bone marrow transplantation for severe aplastic anaemia.
McCann S; Passweg J; Bacigalupo A; Locasciulli A; Locatelli F; Ryan J; Schrezenmeier H; Lawler M
Bone Marrow Transplant; 2007 Jan; 39(2):109-14. PubMed ID: 17173053
[TBL] [Abstract][Full Text] [Related]
25. Improved survival in severe acquired aplastic anemia of childhood.
Fouladi M; Herman R; Rolland-Grinton M; Jones-Wallace D; Blanchette V; Calderwood S; Doyle J; Halperin D; Leaker M; Saunders EF; Zipursky A; Freedman MH
Bone Marrow Transplant; 2000 Dec; 26(11):1149-56. PubMed ID: 11149724
[TBL] [Abstract][Full Text] [Related]
26. Addition of low-dose busulfan to cyclophosphamide in aplastic anemia patients prior to allogeneic bone marrow transplantation to reduce rejection.
Dulley FL; Vigorito AC; Aranha FJ; Sturaro D; Ruiz MA; Saboya R; Macedo MC; Da Silva RL; Chamone DA; Mehta J; Bacigalupo A; De Souza CA
Bone Marrow Transplant; 2004 Jan; 33(1):9-13. PubMed ID: 14578930
[TBL] [Abstract][Full Text] [Related]
27. Cyclophosphamide and antithymocyte globulin conditioning may be sufficient for Korean patients with early stage severe aplastic anemia transplanted with marrow from donors other than HLA-identical siblings.
Lee JH; Lee JH; Lee JS; Kim WK; Chi HS; Lee KH
Haematologica; 2001 Apr; 86(4):434-5. PubMed ID: 11325653
[TBL] [Abstract][Full Text] [Related]
28. Severe acquired aplastic anemia in children: 11-year experience with bone marrow transplantation and immunosuppressive therapy.
Halpérin DS; Grisaru D; Freedman MH; Saunders EF
Am J Pediatr Hematol Oncol; 1989; 11(3):304-9. PubMed ID: 2675660
[TBL] [Abstract][Full Text] [Related]
29. Management of acquired aplastic anaemia.
Marsh JC
Blood Rev; 2005 May; 19(3):143-51. PubMed ID: 15748962
[TBL] [Abstract][Full Text] [Related]
30. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
31. Similar outcome of upfront-unrelated and matched sibling stem cell transplantation in idiopathic paediatric aplastic anaemia. A study on behalf of the UK Paediatric BMT Working Party, Paediatric Diseases Working Party and Severe Aplastic Anaemia Working Party of EBMT.
Dufour C; Veys P; Carraro E; Bhatnagar N; Pillon M; Wynn R; Gibson B; Vora AJ; Steward CG; Ewins AM; Hough RE; de la Fuente J; Velangi M; Amrolia PJ; Skinner R; Bacigalupo A; Risitano AM; Socie G; Peffault de Latour R; Passweg J; Rovo A; Tichelli A; Schrezenmeier H; Hochsmann B; Bader P; van Biezen A; Aljurf MD; Kulasekararaj A; Marsh JC; Samarasinghe S
Br J Haematol; 2015 Nov; 171(4):585-94. PubMed ID: 26223288
[TBL] [Abstract][Full Text] [Related]
32. Prior immunosuppressive therapy with antithymocyte globulin increases the risk of EBV-related lymphoproliferative disorder following allo-SCT for acquired aplastic anaemia.
Buyck HC; Ball S; Junagade P; Marsh J; Chakrabarti S
Bone Marrow Transplant; 2009 May; 43(10):813-6. PubMed ID: 19104495
[TBL] [Abstract][Full Text] [Related]
33. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance.
Stachel D; Schmid I; Lang T; Haas RJ; Otté JB
Transpl Int; 2002 Jan; 15(1):39-44. PubMed ID: 11875612
[TBL] [Abstract][Full Text] [Related]
34. Treatment of acquired severe aplastic anemia.
Katsanis E; Ramsay NK
Am J Pediatr Hematol Oncol; 1989; 11(3):360-7. PubMed ID: 2675662
[TBL] [Abstract][Full Text] [Related]
35. Antithymocyte globulin, cyclosporine, and prednisone for the treatment of severe aplastic anemia in children. A pilot study.
Matloub YH; Bostrom B; Golembe B; Priest J; Ramsay NK
Am J Pediatr Hematol Oncol; 1994 May; 16(2):104-6. PubMed ID: 8166362
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome after bone marrow transplantation for aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning regimen.
Inamoto Y; Suzuki R; Kuwatsuka Y; Yasuda T; Takahashi T; Tsujimura A; Sugimoto K; Oba T; Terakura S; Atsuta Y; Murata M; Ito M; Kodera Y; Miyamura K
Biol Blood Marrow Transplant; 2008 Jan; 14(1):43-9. PubMed ID: 18158960
[TBL] [Abstract][Full Text] [Related]
37. [Results of treatment for severe acquired aplastic anemia in children].
Ochocka M; Karwacki M; Matysiak M; Armata J; Dłuzniewska A; Bogusławska-Jaworska J; Pejcz J; Kowalczyk J; Skomra S; Radwańska U
Pediatr Pol; 1995 Mar; 70(3):205-11. PubMed ID: 8657487
[TBL] [Abstract][Full Text] [Related]
38. The benefit of ATG in immunosuppressive therapy of children with moderate aplastic anemia.
Jiang S; Wang Y; Shi W; Shao Y; Qiao X; Lin J; Kuang H; Xie X
Pediatr Hematol Oncol; 2009; 26(5):313-20. PubMed ID: 19579077
[TBL] [Abstract][Full Text] [Related]
39. Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell transplantation for severe aplastic anemia.
George B; Mathews V; Viswabandya A; Kavitha ML; Srivastava A; Chandy M
Bone Marrow Transplant; 2007 Jul; 40(1):13-8. PubMed ID: 17450183
[TBL] [Abstract][Full Text] [Related]
40. Outcome of children with aplastic anemia treated with immunosuppressive therapy.
Pongtanakul B; Das PK; Charpentier K; Dror Y
Pediatr Blood Cancer; 2008 Jan; 50(1):52-7. PubMed ID: 17941069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]